Pharmaceutical

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Mankind Pharma has announced a definitive agreement for the acquisition of Bharat Serums and Vaccines (BSV) for Rs136.3bn ($1.6bn).

Jul 28, 2024 - 04:00
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of Bharat Serums and Vaccines (BSV) for Rs136.3bn ($1.6bn).
Read the original article

Tags:

Previous Article

Roche records 4% decline in H1 2024 net income

Next Article

AbbVie’s Q2 2024 net earnings drop to $1.37bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ProductLife boosts drug development with IntiQuan acquisition

ProductLife boosts drug development with IntiQuan acqui...

Oct 8, 2024

Trump triumphs but impact on healthcare industry remains unclear

Trump triumphs but impact on healthcare industry remain...

Nov 7, 2024

BioNTech and DualityBio team up to develop ADC therapeutics for cancer

BioNTech and DualityBio team up to develop ADC therapeu...

Apr 3, 2023